×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VNRX – volitionrx limited (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VNRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
01:28 pm
vnrx
VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
Low
Report
VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
12/4
09:00 am
vnrx
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
Medium
Report
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
12/3
02:19 pm
vnrx
VolitionRx (NYSE:VNRX) had its "hold" rating reaffirmed by analysts at Maxim Group.
Low
Report
VolitionRx (NYSE:VNRX) had its "hold" rating reaffirmed by analysts at Maxim Group.
11/26
12:56 pm
vnrx
VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
Low
Report
VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
11/25
09:10 am
vnrx
VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use [Yahoo! Finance]
Low
Report
VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use [Yahoo! Finance]
11/25
08:45 am
vnrx
VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use
High
Report
VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use
11/17
12:01 pm
vnrx
VolitionRx (NYSE:VNRX) had its price target lowered by analysts at HC Wainwright from $2.50 to $1.50. They now have a "buy" rating on the stock.
Low
Report
VolitionRx (NYSE:VNRX) had its price target lowered by analysts at HC Wainwright from $2.50 to $1.50. They now have a "buy" rating on the stock.
11/17
08:20 am
vnrx
VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
Medium
Report
VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/17
01:12 pm
vnrx
Form 4 VOLITIONRX LTD For: Nov 17 Filed by: Reynolds Cameron John
Low
Report
Form 4 VOLITIONRX LTD For: Nov 17 Filed by: Reynolds Cameron John
11/14
06:29 pm
vnrx
Form SCHEDULE 13G/A VOLITIONRX LTD Filed by: ARMISTICE CAPITAL, LLC
Medium
Report
Form SCHEDULE 13G/A VOLITIONRX LTD Filed by: ARMISTICE CAPITAL, LLC
11/10
05:05 pm
vnrx
Form 8-K/A VOLITIONRX LTD For: Nov 07
Medium
Report
Form 8-K/A VOLITIONRX LTD For: Nov 07
11/7
05:30 pm
vnrx
Form 8-K VOLITIONRX LTD For: Nov 07
Low
Report
Form 8-K VOLITIONRX LTD For: Nov 07
11/4
04:02 pm
vnrx
Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Plummer Nicholas
Medium
Report
Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Plummer Nicholas
11/4
04:02 pm
vnrx
Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Retter Andrew
Medium
Report
Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Retter Andrew
11/4
04:01 pm
vnrx
Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Butera Salvatore Thomas
Medium
Report
Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Butera Salvatore Thomas
11/4
04:01 pm
vnrx
Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Rootsaert Rodney Gerard
Medium
Report
Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Rootsaert Rodney Gerard
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
9/17
Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes
10.1%
2/7 Form S-3 VOLITIONRX LTD 9.4%
11/7 VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update 8.6%
10/18 Form 4 VOLITIONRX LTD For: Oct 01 Filed by: Cotterford Co Ltd 6.4%
7/10 VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding 6.3%
8/16 Form 4 VOLITIONRX LTD For: Aug 15 Filed by: Faulkes Martin Charles 5.5%
3/22 VolitionRx (VNRX) Investor Presentation - Slideshow [Seeking Alpha] 5.4%
10/18 Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas 4.6%
4/1 Form PRE 14A VOLITIONRX LTD For: Apr 01 4.2%
11/12 Form 10-Q VOLITIONRX LTD For: Sep 30 4.1%
2/7 Form S-3 VOLITIONRX LTD 9.4%
11/7 VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update 8.6%
10/18 Form 4 VOLITIONRX LTD For: Oct 01 Filed by: Cotterford Co Ltd 6.4%
7/10 VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding 6.3%
8/16 Form 4 VOLITIONRX LTD For: Aug 15 Filed by: Faulkes Martin Charles 5.5%
3/22 VolitionRx (VNRX) Investor Presentation - Slideshow [Seeking Alpha] 5.4%
10/18 Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas 4.6%
4/1 Form PRE 14A VOLITIONRX LTD For: Apr 01 4.2%
11/12 Form 10-Q VOLITIONRX LTD For: Sep 30 4.1%
TOP News Decliners
12/5
VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test
-13.4%
2/21 VolitionRx Limited 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] -10.5%
4/23 Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies -10.2%
2/27 Form 4 VOLITIONRX LTD For: Feb 26 Filed by: TERRELL JASON BRADLEY MD -9.8%
3/10 VolitionRx Limited Releases Annual Corporate Brochure and Video -7.2%
7/24 Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock -6.7%
4/29 Form DEF 14A VOLITIONRX LTD For: Apr 29 -5.3%
8/1 Form SC 13D VOLITIONRX LTD Filed by: Cotterford Co Ltd -3.7%
5/8 VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update -3.2%
8/8 Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer -3.0%
2/21 VolitionRx Limited 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] -10.5%
4/23 Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies -10.2%
2/27 Form 4 VOLITIONRX LTD For: Feb 26 Filed by: TERRELL JASON BRADLEY MD -9.8%
3/10 VolitionRx Limited Releases Annual Corporate Brochure and Video -7.2%
7/24 Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock -6.7%
4/29 Form DEF 14A VOLITIONRX LTD For: Apr 29 -5.3%
8/1 Form SC 13D VOLITIONRX LTD Filed by: Cotterford Co Ltd -3.7%
5/8 VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update -3.2%
8/8 Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer -3.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: